Navigation Links
EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Date:8/19/2007

LYON, France, Aug. 17 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, is currently conducting clinical investigations in France under an approved clinical trial combining the company's Ablatherm-HIFU device with chemotherapy using docetaxel.

The study is a primary treatment therapy program for men suffering from clinically localized but aggressive high risk prostate cancer typically classified as stage T2c. The study began in late 2006 and will enroll a total of 30 men, of which more than 10 have already been treated.

"Combination therapy is well documented as a treatment protocol for men suffering more aggressive prostate cancers," said Dr. Albert Gelet, Edouard Herriot Hospital, Lyon. "Ablatherm-HIFU is a proven effective treatment for localized prostate cancer already with strong clinical support. This study aims to evaluate its use under an additional dedicated protocol for men in the T2c cancer stage where the tumors are known to be more aggressive, creating a higher risk of relapse if the patient is treated with only a localized therapy. It was demonstrated in pre-clinical studies that HIFU improves chemotherapy drug efficacy in the area around burned tissues."

Under the approved protocol by French Ethical Committee, patients are administered a dose of docetaxel 30 minutes prior to a standard primary indication HIFU session lasting an average of two hours. The Ablatherm-HIFU ablates the prostate tissue according to conventional procedures and protocols. All treatments are administered at Edouard Herriot Hospital in Lyon, France.

"EDAP has a strong scientific and clinical base underlying the Ablatherm-HIFU, with constant work to enhance and extend the capabilities of the device," said Pr John Rewcastle, Medical Director for EDAP. "With already well documented specialized protocols for primary therapy, HIFU retreatment and salvage th
'/>"/>

SOURCE EDAP TMS S.A.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015  Konica Minolta, Inc. (Konica Minolta) ( ... has acquired Sawae Technologica Ltda., an X-ray system equipment ... , through its Brazilian healthcare sales company, Konica Minolta ... Local Brazil market investment and ... exceeding 200 million, significant healthcare technical advancements and efficiencies ...
(Date:7/2/2015)... SHENZHEN, China , 2 de julio de 2015 ... secuenciación de ADN de alto rendimiento en ... por el American College of Pathologists (CAP). La instalación de ... el primer laboratorio de secuenciación de próxima generación que ... , cubriendo el más alto estándar en prácticas de ...
(Date:7/2/2015)... NORTH CHICAGO, Ill. , July 2, 2015 /PRNewswire/ ... 2015 financial results on Friday, July 24, 2015, before ... live webcast of the earnings conference call at 8 ... accessible through AbbVie,s Investor Relations website at www.abbvieinvestor.com ... available after 11 a.m. Central time. About ...
Breaking Medicine Technology:Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3BGI recibe la acreditación del College of American Pathologists (CAP) 2
... 3, 2011 NxStage® Medical, Inc. (Nasdaq: ... today reported record financial results for the second quarter ... well above the top end of its guidance range. ... the second quarter of 2011 increased to $53.8 million, ...
... Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), ... that the United States Patent and Trademark Office has ... patent application directed to the fundamental technology involved in ... delivery systems. The allowable subject matter is directed to ...
Cached Medicine Technology:NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 2NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 3NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 4NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 5NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 6NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 7NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 8Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology 2Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology 3Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology 4
(Date:7/3/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich , ... held from March 4th - 6th, the 2016 (a previous announcement had stated the ... to take participants from the basic training and fundamentals of nasal surgery through the ...
(Date:7/3/2015)... ... 03, 2015 , ... B. E. Smith, the only full-service ... a national chief nursing officer recruitment for Jane Phillips Medical Center ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Smoothies are ... is a good blender and easily accessible, quality ingredients. Aurora Natural is proud to ... for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the ... , the largest network of independent freestanding emergency rooms in the United States. , ... our Sienna Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a ... features the latest and coolest technology products available to consumers. Amanda Forstrom, a technology ... these selfie sticks are great for documenting memories. , Almost every smartphone has an ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Learn How to Take Selfies like Kendall Jenner 2
... January 2008)Twenty-one boxes filled with 7,000 unique seed samples ... the Svalbard Global Seed Vault, a facility being built ... a repository of last resort for humanitys agricultural heritage. ... government as a service to the global community, and ...
... 19 commonly eaten fruits for the antioxidant,advantage, ... Service Report from USDA, containing the results of,the ... cranberries,score among the highest of all common fruits ... report includes antioxidant values for a wide variety ...
... normal-size heads at birth but develop accelerated head growth ... that precedes the onset of many behaviors that enable ... research from the University of Washingtons Autism Center., The ... in children who have the early onset form of ...
... been found that influences the response of the heart to ... during a heart attack, a team of Yale School of ... present a new therapeutic approach to treating loss of blood ... migration inhibitory factor (MIF), was found to activate an important ...
... the focus of this inaugural ... ... Mount Abbe,in the northern reaches of Alaska,s Glacier Bay National Park ... a quest,sponsored by Fred Hutchinson Cancer Research Center, with interdisciplinary,teams of ...
... Therapeutics (Prime) has,joined the Center for Health Value ... manager (PBM) industry. The Center for Health Value,Innovation ... to develop and promote innovative value-based health,strategies with ... employees. Members,of the Center represent various sectors of ...
Cached Medicine News:Health News:African seed collection first to arrive in Norway on route to Arctic seed vault 2Health News:African seed collection first to arrive in Norway on route to Arctic seed vault 3Health News:Cranberries' Antioxidant Level Tops List in USDA Report 2Health News:Cranberries' Antioxidant Level Tops List in USDA Report 3Health News:Accelerated head growth can predict autism before behavioral symptoms start 2Health News:Hutchinson Center Announces First Unclimbed Mountain to be Tackled by Big Expedition for Cancer Research 2Health News:Prime Therapeutics Becomes First PBM to Join the Center for Health Value Innovation 2
... part of the Freedom Urinary Collection ... bags, kits, and accessories designed to ... customers. These leg bags are offered ... 100% latex-free soft, textured medical grade ...
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
... easy on delicate urethral tissues. ... hydrophilic coating provide nearly friction-free ... It's easy to maintain sterility. ... with its own sterile water, ...
... easy on delicate urethral tissues. ... hydrophilic coating provide nearly friction-free ... It's easy to maintain sterility. ... with its own sterile water, ...
Medicine Products: